For its third fiscal quarter (ending September 30), Laboratory Corp of America Holdi (NYSE: LH) has reported a -5% decline in E.P.S. from $2.12 a year ago to $2.02 in the current quarter. For the latest four quarters through September 30, E.P.S. were $5.20 compared to $6.64 a year ago — a decline of -22%.
Recent Price Action
On 10/24/24, Laboratory Corp of America Holdi (NYSE: LH) stock enjoyed a large increase of 4.6%, closing at $230.07. Moreover, exceptionally high trading volume at 318% of normal accompanied the advance. The stock has performed in line with the market over the last nine months and has risen 6.2% during the last week.
Current PriceTarget Research Rating
LH is expected to continue to be a major Value Builder reflecting capital returns that are forecasted to be above the cost of capital.
Laboratory has a current Value Trend Rating of C (Low Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. Laboratory has a slightly negative Appreciation Score of 35 and a neutral Power Rating of 55, with the Low Neutral Value Trend Rating the result.
Rating Review
In light of this new information we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment